

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T cell migration (GO:0072678) | 7.63658379 |
| 2 | cytidine metabolic process (GO:0046087) | 7.43835094 |
| 3 | cytidine catabolic process (GO:0006216) | 7.43835094 |
| 4 | cytidine deamination (GO:0009972) | 7.43835094 |
| 5 | negative T cell selection (GO:0043383) | 7.34752231 |
| 6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 7.10819048 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.89314700 |
| 8 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.84612954 |
| 9 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.67625302 |
| 10 | positive T cell selection (GO:0043368) | 6.27688631 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.13006667 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.87656611 |
| 13 | DNA deamination (GO:0045006) | 5.79957264 |
| 14 | negative thymic T cell selection (GO:0045060) | 5.75842371 |
| 15 | positive regulation of interleukin-8 secretion (GO:2000484) | 5.64070587 |
| 16 | positive thymic T cell selection (GO:0045059) | 5.34031479 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 5.07117263 |
| 18 | cellular response to interleukin-15 (GO:0071350) | 4.92577490 |
| 19 | T cell receptor signaling pathway (GO:0050852) | 4.82115280 |
| 20 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.81690389 |
| 21 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.75619612 |
| 22 | interferon-gamma production (GO:0032609) | 4.74060057 |
| 23 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.63044262 |
| 24 | lymphocyte chemotaxis (GO:0048247) | 4.60522590 |
| 25 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.59759667 |
| 26 | regulation of regulatory T cell differentiation (GO:0045589) | 4.59173493 |
| 27 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.49572794 |
| 28 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.45410212 |
| 29 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.42193792 |
| 30 | thymic T cell selection (GO:0045061) | 4.39461509 |
| 31 | chemokine-mediated signaling pathway (GO:0070098) | 4.39294714 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.38067348 |
| 33 | mast cell activation (GO:0045576) | 4.37831863 |
| 34 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.34522382 |
| 35 | response to interleukin-15 (GO:0070672) | 4.32061763 |
| 36 | negative regulation of T cell apoptotic process (GO:0070233) | 4.31336420 |
| 37 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.30088015 |
| 38 | T cell selection (GO:0045058) | 4.27192153 |
| 39 | lymphocyte migration (GO:0072676) | 4.22354966 |
| 40 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.21689294 |
| 41 | positive regulation of granulocyte differentiation (GO:0030854) | 4.18833102 |
| 42 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.11485226 |
| 43 | leukocyte aggregation (GO:0070486) | 4.11380432 |
| 44 | positive regulation of B cell differentiation (GO:0045579) | 4.10231431 |
| 45 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.09292850 |
| 46 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.05695510 |
| 47 | negative regulation of cell killing (GO:0031342) | 4.05695510 |
| 48 | regulation of interleukin-8 secretion (GO:2000482) | 4.01649132 |
| 49 | regulation of B cell differentiation (GO:0045577) | 4.01117252 |
| 50 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.99015934 |
| 51 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.99015934 |
| 52 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.96904578 |
| 53 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.93398438 |
| 54 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.93207834 |
| 55 | regulation of defense response to virus by virus (GO:0050690) | 3.82939973 |
| 56 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.81187611 |
| 57 | T cell costimulation (GO:0031295) | 3.76502906 |
| 58 | lymphocyte costimulation (GO:0031294) | 3.71697934 |
| 59 | actin nucleation (GO:0045010) | 3.68642264 |
| 60 | positive regulation of lymphocyte migration (GO:2000403) | 3.58670549 |
| 61 | negative regulation by host of viral transcription (GO:0043922) | 3.58620419 |
| 62 | positive regulation of cell killing (GO:0031343) | 3.51298411 |
| 63 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.50681817 |
| 64 | eosinophil chemotaxis (GO:0048245) | 3.46544883 |
| 65 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.46022461 |
| 66 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.46017066 |
| 67 | regulation of cell killing (GO:0031341) | 3.44447179 |
| 68 | cellular defense response (GO:0006968) | 3.39253229 |
| 69 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.37711654 |
| 70 | negative regulation of viral genome replication (GO:0045071) | 3.36132328 |
| 71 | regulation of T cell chemotaxis (GO:0010819) | 3.35425506 |
| 72 | positive regulation of T cell chemotaxis (GO:0010820) | 3.35425506 |
| 73 | T cell differentiation (GO:0030217) | 3.35044128 |
| 74 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.33812835 |
| 75 | positive regulation of humoral immune response (GO:0002922) | 3.33123985 |
| 76 | negative regulation of viral transcription (GO:0032897) | 3.29456549 |
| 77 | lymph node development (GO:0048535) | 3.28563577 |
| 78 | regulation of T cell apoptotic process (GO:0070232) | 3.28531750 |
| 79 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.28383849 |
| 80 | regulation of calcium-mediated signaling (GO:0050848) | 3.27447884 |
| 81 | dendritic cell chemotaxis (GO:0002407) | 3.20786199 |
| 82 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.20572758 |
| 83 | viral genome replication (GO:0019079) | 3.16464982 |
| 84 | regulation of activation of Janus kinase activity (GO:0010533) | 3.15373285 |
| 85 | eosinophil migration (GO:0072677) | 3.13550859 |
| 86 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.08918103 |
| 87 | B cell receptor signaling pathway (GO:0050853) | 3.08591449 |
| 88 | negative regulation of bone resorption (GO:0045779) | 3.07239783 |
| 89 | ncRNA 3-end processing (GO:0043628) | 3.05229612 |
| 90 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.03594322 |
| 91 | negative regulation of glycogen biosynthetic process (GO:0045719) | 3.03001592 |
| 92 | cytolysis (GO:0019835) | 3.02682302 |
| 93 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.02421788 |
| 94 | T cell mediated immunity (GO:0002456) | 3.01599535 |
| 95 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.99413484 |
| 96 | mast cell activation involved in immune response (GO:0002279) | 2.99132531 |
| 97 | mast cell degranulation (GO:0043303) | 2.99132531 |
| 98 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.98701427 |
| 99 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.94390082 |
| 100 | T cell activation (GO:0042110) | 2.93135087 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.02768885 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.27772147 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.12549016 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.64528790 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.50993350 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.26155197 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.64712122 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.58915976 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.45998867 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 3.45590031 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.44073854 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.96617261 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.89920580 |
| 14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.77703067 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.76764231 |
| 16 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.71954914 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.57193285 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.56999240 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.49376828 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 2.48147226 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.30225751 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.27551382 |
| 23 | UTX_26944678_Chip-Seq_JUKART_Human | 2.22518656 |
| 24 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.15320031 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90357242 |
| 26 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.89583425 |
| 27 | GATA3_26560356_Chip-Seq_TH2_Human | 1.89442848 |
| 28 | MAF_26560356_Chip-Seq_TH2_Human | 1.87790688 |
| 29 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.81408892 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.76971200 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.72678874 |
| 32 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.71477419 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56543176 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.52314092 |
| 35 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52295070 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49335794 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48790291 |
| 38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.43447656 |
| 39 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.38993797 |
| 40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.35820441 |
| 41 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.28172178 |
| 42 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.21125986 |
| 43 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.19460737 |
| 44 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17830116 |
| 45 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15165116 |
| 46 | P300_27268052_Chip-Seq_Bcells_Human | 1.13296157 |
| 47 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13086449 |
| 48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12927482 |
| 49 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11301480 |
| 50 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.10403698 |
| 51 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07779098 |
| 52 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.02487525 |
| 53 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.02375007 |
| 54 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.02148606 |
| 55 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.01187490 |
| 56 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.01164358 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00853510 |
| 58 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00430632 |
| 59 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00399838 |
| 60 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.99699536 |
| 61 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.98360897 |
| 62 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.98360897 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96408009 |
| 64 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.93699306 |
| 65 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.91784828 |
| 66 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.91494535 |
| 67 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90423499 |
| 68 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.89981420 |
| 69 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88782046 |
| 70 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.88075833 |
| 71 | SPI1_23127762_ChIP-Seq_K562_Human | 0.87618827 |
| 72 | GATA3_26560356_Chip-Seq_TH1_Human | 0.87069490 |
| 73 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.83302518 |
| 74 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82821827 |
| 75 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82806310 |
| 76 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.81441837 |
| 77 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.81426030 |
| 78 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81344077 |
| 79 | NCOR_22424771_ChIP-Seq_293T_Human | 0.79971418 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.79456369 |
| 81 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79084310 |
| 82 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.78000411 |
| 83 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.77890287 |
| 84 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.77509943 |
| 85 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.75654662 |
| 86 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.75050255 |
| 87 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.74359434 |
| 88 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.73174323 |
| 89 | AR_20517297_ChIP-Seq_VCAP_Human | 0.71482332 |
| 90 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.70570024 |
| 91 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.70234802 |
| 92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.69487088 |
| 93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.68352909 |
| 94 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.66774032 |
| 95 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.66728928 |
| 96 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.66469801 |
| 97 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.65897484 |
| 98 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.65710408 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.65512436 |
| 100 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.65238282 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.14146279 |
| 2 | MP0003763_abnormal_thymus_physiology | 5.17876234 |
| 3 | MP0009785_altered_susceptibility_to | 4.11642101 |
| 4 | MP0003866_abnormal_defecation | 3.29485884 |
| 5 | MP0009333_abnormal_splenocyte_physiolog | 3.10569101 |
| 6 | MP0005000_abnormal_immune_tolerance | 2.94411715 |
| 7 | MP0001800_abnormal_humoral_immune | 2.94098535 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.89528812 |
| 9 | MP0005025_abnormal_response_to | 2.71486019 |
| 10 | MP0006082_CNS_inflammation | 2.69883211 |
| 11 | MP0003646_muscle_fatigue | 2.64477962 |
| 12 | MP0002723_abnormal_immune_serum | 2.60255255 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.57980586 |
| 14 | MP0004381_abnormal_hair_follicle | 2.53676206 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.52158010 |
| 16 | MP0001819_abnormal_immune_cell | 2.50649869 |
| 17 | MP0000703_abnormal_thymus_morphology | 2.28663452 |
| 18 | MP0003436_decreased_susceptibility_to | 2.25276910 |
| 19 | MP0003878_abnormal_ear_physiology | 2.19462307 |
| 20 | MP0005377_hearing/vestibular/ear_phenot | 2.19462307 |
| 21 | MP0005075_abnormal_melanosome_morpholog | 2.16848022 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.12071546 |
| 23 | MP0003045_fibrosis | 2.08135487 |
| 24 | MP0000685_abnormal_immune_system | 2.06185110 |
| 25 | MP0010155_abnormal_intestine_physiology | 2.01019717 |
| 26 | MP0002405_respiratory_system_inflammati | 2.00930733 |
| 27 | MP0002398_abnormal_bone_marrow | 1.97431645 |
| 28 | MP0000716_abnormal_immune_system | 1.93771542 |
| 29 | MP0003724_increased_susceptibility_to | 1.91535371 |
| 30 | MP0003787_abnormal_imprinting | 1.84601849 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.81332886 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.79717090 |
| 33 | MP0002722_abnormal_immune_system | 1.79463877 |
| 34 | MP0002419_abnormal_innate_immunity | 1.78382829 |
| 35 | MP0001790_abnormal_immune_system | 1.74363767 |
| 36 | MP0005387_immune_system_phenotype | 1.74363767 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.61577848 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.55229982 |
| 39 | MP0005166_decreased_susceptibility_to | 1.51629603 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.50423461 |
| 41 | MP0002102_abnormal_ear_morphology | 1.49299764 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.47337008 |
| 43 | MP0003448_altered_tumor_morphology | 1.44845826 |
| 44 | MP0009764_decreased_sensitivity_to | 1.42053049 |
| 45 | MP0002429_abnormal_blood_cell | 1.40814398 |
| 46 | MP0004145_abnormal_muscle_electrophysio | 1.35475440 |
| 47 | MP0002006_tumorigenesis | 1.26036427 |
| 48 | MP0002693_abnormal_pancreas_physiology | 1.21625837 |
| 49 | MP0008469_abnormal_protein_level | 1.20462875 |
| 50 | MP0002933_joint_inflammation | 1.18228402 |
| 51 | MP0000569_abnormal_digit_pigmentation | 1.16551324 |
| 52 | MP0009763_increased_sensitivity_to | 1.13869440 |
| 53 | MP0002163_abnormal_gland_morphology | 1.13452712 |
| 54 | MP0008260_abnormal_autophagy | 1.06595451 |
| 55 | MP0004947_skin_inflammation | 1.02996737 |
| 56 | MP0001919_abnormal_reproductive_system | 1.01647163 |
| 57 | MP0003195_calcinosis | 0.98004866 |
| 58 | MP0001542_abnormal_bone_strength | 0.97790202 |
| 59 | MP0001533_abnormal_skeleton_physiology | 0.90072758 |
| 60 | MP0005360_urolithiasis | 0.88250294 |
| 61 | MP0009643_abnormal_urine_homeostasis | 0.87051591 |
| 62 | MP0009765_abnormal_xenobiotic_induced | 0.85445738 |
| 63 | MP0004883_abnormal_blood_vessel | 0.83653460 |
| 64 | MP0000015_abnormal_ear_pigmentation | 0.83241298 |
| 65 | MP0003690_abnormal_glial_cell | 0.82664046 |
| 66 | MP0002136_abnormal_kidney_physiology | 0.80358504 |
| 67 | MP0001764_abnormal_homeostasis | 0.78257874 |
| 68 | MP0002019_abnormal_tumor_incidence | 0.76234869 |
| 69 | MP0000372_irregular_coat_pigmentation | 0.72925023 |
| 70 | MP0001984_abnormal_olfaction | 0.72903156 |
| 71 | MP0005389_reproductive_system_phenotype | 0.72830274 |
| 72 | MP0002095_abnormal_skin_pigmentation | 0.72239019 |
| 73 | MP0003075_altered_response_to | 0.71728444 |
| 74 | MP0000858_altered_metastatic_potential | 0.70266089 |
| 75 | MP0003880_abnormal_central_pattern | 0.69609190 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 0.66726701 |
| 77 | MP0001485_abnormal_pinna_reflex | 0.66089207 |
| 78 | MP0002168_other_aberrant_phenotype | 0.64057777 |
| 79 | MP0000490_abnormal_crypts_of | 0.63819474 |
| 80 | MP0000604_amyloidosis | 0.63716831 |
| 81 | MP0001765_abnormal_ion_homeostasis | 0.63491637 |
| 82 | MP0003011_delayed_dark_adaptation | 0.63207050 |
| 83 | MP0005310_abnormal_salivary_gland | 0.62639145 |
| 84 | MP0005551_abnormal_eye_electrophysiolog | 0.58872571 |
| 85 | MP0000920_abnormal_myelination | 0.58247245 |
| 86 | MP0005058_abnormal_lysosome_morphology | 0.57135747 |
| 87 | MP0002998_abnormal_bone_remodeling | 0.57119525 |
| 88 | MP0003137_abnormal_impulse_conducting | 0.56441870 |
| 89 | MP0000477_abnormal_intestine_morphology | 0.56350004 |
| 90 | MP0003786_premature_aging | 0.55420525 |
| 91 | MP0008873_increased_physiological_sensi | 0.53930518 |
| 92 | MP0001243_abnormal_dermal_layer | 0.53795631 |
| 93 | MP0005332_abnormal_amino_acid | 0.51666332 |
| 94 | MP0001905_abnormal_dopamine_level | 0.51630119 |
| 95 | MP0005266_abnormal_metabolism | 0.50829849 |
| 96 | MP0010386_abnormal_urinary_bladder | 0.49436110 |
| 97 | MP0003693_abnormal_embryo_hatching | 0.49302581 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.49148827 |
| 99 | MP0005379_endocrine/exocrine_gland_phen | 0.47364071 |
| 100 | MP0002083_premature_death | 0.46264973 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 8.90342416 |
| 2 | Abnormality of T cell number (HP:0011839) | 8.19444422 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 6.91576805 |
| 4 | Abnormality of T cells (HP:0002843) | 6.27212459 |
| 5 | Combined immunodeficiency (HP:0005387) | 5.65597063 |
| 6 | Aplastic anemia (HP:0001915) | 5.59444162 |
| 7 | Stomatitis (HP:0010280) | 5.05332714 |
| 8 | Autoimmune hemolytic anemia (HP:0001890) | 5.05155514 |
| 9 | IgG deficiency (HP:0004315) | 5.02108347 |
| 10 | Thyroiditis (HP:0100646) | 4.52586019 |
| 11 | Chronic diarrhea (HP:0002028) | 4.35244818 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.17480027 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 4.17449719 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 4.08335045 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 3.97575950 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.97575950 |
| 17 | Recurrent bronchitis (HP:0002837) | 3.97241127 |
| 18 | Abnormality of T cell physiology (HP:0011840) | 3.92857643 |
| 19 | IgM deficiency (HP:0002850) | 3.77490182 |
| 20 | Abnormality of eosinophils (HP:0001879) | 3.76517877 |
| 21 | Hypoproteinemia (HP:0003075) | 3.65915292 |
| 22 | Autoimmune thrombocytopenia (HP:0001973) | 3.52752681 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.49641401 |
| 24 | Hypoplasia of the thymus (HP:0000778) | 3.39361542 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.36987682 |
| 26 | Eczematoid dermatitis (HP:0000976) | 3.34349981 |
| 27 | Recurrent fungal infections (HP:0002841) | 3.34184209 |
| 28 | Recurrent viral infections (HP:0004429) | 3.16957474 |
| 29 | Lymphopenia (HP:0001888) | 3.10341201 |
| 30 | Leukocytosis (HP:0001974) | 2.97866247 |
| 31 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.95974940 |
| 32 | Abnormality of B cell number (HP:0010975) | 2.91707039 |
| 33 | Agammaglobulinemia (HP:0004432) | 2.90976264 |
| 34 | Recurrent skin infections (HP:0001581) | 2.89460578 |
| 35 | B lymphocytopenia (HP:0010976) | 2.75956278 |
| 36 | Congenital stationary night blindness (HP:0007642) | 2.74492747 |
| 37 | Eosinophilia (HP:0001880) | 2.69794817 |
| 38 | Meningitis (HP:0001287) | 2.69731441 |
| 39 | Vasculitis (HP:0002633) | 2.69239221 |
| 40 | Lymphoma (HP:0002665) | 2.68988501 |
| 41 | Obstructive lung disease (HP:0006536) | 2.65430255 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 2.65430255 |
| 43 | Recurrent bacterial skin infections (HP:0005406) | 2.60638050 |
| 44 | Pigmentary retinal degeneration (HP:0001146) | 2.60417679 |
| 45 | Bronchitis (HP:0012387) | 2.54959264 |
| 46 | Acute hepatic failure (HP:0006554) | 2.51463885 |
| 47 | Abnormality of the prostate (HP:0008775) | 2.49686034 |
| 48 | Encephalitis (HP:0002383) | 2.36603739 |
| 49 | Mediastinal lymphadenopathy (HP:0100721) | 2.35654386 |
| 50 | Joint swelling (HP:0001386) | 2.35402375 |
| 51 | Hemiplegia (HP:0002301) | 2.34242750 |
| 52 | Tetany (HP:0001281) | 2.31166047 |
| 53 | Recurrent abscess formation (HP:0002722) | 2.22148273 |
| 54 | Gangrene (HP:0100758) | 2.21460356 |
| 55 | Hyperlipoproteinemia (HP:0010980) | 2.17352713 |
| 56 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.15950087 |
| 57 | Carpal bone hypoplasia (HP:0001498) | 2.14907378 |
| 58 | Increased circulating renin level (HP:0000848) | 2.14536615 |
| 59 | Abnormal albumin level (HP:0012116) | 2.13607261 |
| 60 | Hypoalbuminemia (HP:0003073) | 2.13607261 |
| 61 | Chest pain (HP:0100749) | 2.12239399 |
| 62 | Mitochondrial inheritance (HP:0001427) | 2.11752974 |
| 63 | Diplopia (HP:0000651) | 2.10203364 |
| 64 | Abnormality of binocular vision (HP:0011514) | 2.10203364 |
| 65 | Genetic anticipation (HP:0003743) | 2.09990208 |
| 66 | Abnormality of the alveolar ridges (HP:0006477) | 2.09415077 |
| 67 | Amaurosis fugax (HP:0100576) | 2.07650349 |
| 68 | Stomach cancer (HP:0012126) | 2.07147765 |
| 69 | Granulocytopenia (HP:0001913) | 2.05874035 |
| 70 | Hemoptysis (HP:0002105) | 1.98765645 |
| 71 | Pulmonary infiltrates (HP:0002113) | 1.96884109 |
| 72 | Premature graying of hair (HP:0002216) | 1.90817295 |
| 73 | Retrobulbar optic neuritis (HP:0100654) | 1.89381514 |
| 74 | Optic neuritis (HP:0100653) | 1.89381514 |
| 75 | Ureteral stenosis (HP:0000071) | 1.89028626 |
| 76 | Hepatocellular necrosis (HP:0001404) | 1.87927403 |
| 77 | Recurrent otitis media (HP:0000403) | 1.86994057 |
| 78 | Pancytopenia (HP:0001876) | 1.84891149 |
| 79 | Vacuolated lymphocytes (HP:0001922) | 1.84745427 |
| 80 | Anorexia (HP:0002039) | 1.82897227 |
| 81 | Renal cortical cysts (HP:0000803) | 1.81483069 |
| 82 | Pustule (HP:0200039) | 1.78822688 |
| 83 | Bronchiectasis (HP:0002110) | 1.75546546 |
| 84 | Ureteral obstruction (HP:0006000) | 1.73736497 |
| 85 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.73495883 |
| 86 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.73357758 |
| 87 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.69988030 |
| 88 | Recurrent sinusitis (HP:0011108) | 1.69673467 |
| 89 | Hypomagnesemia (HP:0002917) | 1.68050905 |
| 90 | Increased IgM level (HP:0003496) | 1.66448275 |
| 91 | Abolished electroretinogram (ERG) (HP:0000550) | 1.66109597 |
| 92 | Acute necrotizing encephalopathy (HP:0006965) | 1.65680161 |
| 93 | Pulmonary embolism (HP:0002204) | 1.63691939 |
| 94 | Arterial thrombosis (HP:0004420) | 1.63361500 |
| 95 | Hepatic necrosis (HP:0002605) | 1.62196673 |
| 96 | Reduced antithrombin III activity (HP:0001976) | 1.62149435 |
| 97 | Severe global developmental delay (HP:0011344) | 1.61476150 |
| 98 | Abnormal drinking behavior (HP:0030082) | 1.60996696 |
| 99 | Polydipsia (HP:0001959) | 1.60996696 |
| 100 | Cerebral hypomyelination (HP:0006808) | 1.58940683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 7.64434903 |
| 2 | TESK2 | 6.05853767 |
| 3 | KDR | 3.80806516 |
| 4 | MAP4K1 | 3.69380138 |
| 5 | ITK | 3.34549341 |
| 6 | PASK | 3.20934259 |
| 7 | MAP3K12 | 2.47708652 |
| 8 | ZAP70 | 2.37771351 |
| 9 | TESK1 | 2.30788775 |
| 10 | FES | 2.26401921 |
| 11 | TEC | 2.18460255 |
| 12 | CSK | 1.87762240 |
| 13 | SYK | 1.86720125 |
| 14 | TAOK3 | 1.83415577 |
| 15 | MAP3K11 | 1.79472177 |
| 16 | BTK | 1.72186280 |
| 17 | SCYL2 | 1.63735017 |
| 18 | EIF2AK3 | 1.56482527 |
| 19 | JAK3 | 1.56011118 |
| 20 | BCKDK | 1.54006882 |
| 21 | MST4 | 1.50267850 |
| 22 | LIMK1 | 1.47716439 |
| 23 | RPS6KA4 | 1.45208853 |
| 24 | GRK6 | 1.42766916 |
| 25 | CAMKK1 | 1.42362722 |
| 26 | NLK | 1.37581468 |
| 27 | LCK | 1.34994671 |
| 28 | MAPKAPK3 | 1.31580169 |
| 29 | PRKCQ | 1.30703896 |
| 30 | LYN | 1.27477922 |
| 31 | ADRBK2 | 1.19923631 |
| 32 | RIPK4 | 1.07714843 |
| 33 | HCK | 1.03293483 |
| 34 | TNK2 | 1.02356260 |
| 35 | CLK1 | 0.95293802 |
| 36 | IRAK4 | 0.94924757 |
| 37 | FRK | 0.82478464 |
| 38 | CSF1R | 0.78941168 |
| 39 | FYN | 0.77367678 |
| 40 | NUAK1 | 0.76127523 |
| 41 | IKBKE | 0.73881636 |
| 42 | BMX | 0.67985166 |
| 43 | ZAK | 0.65249733 |
| 44 | BUB1 | 0.65119583 |
| 45 | RPS6KA5 | 0.64907000 |
| 46 | IGF1R | 0.62051038 |
| 47 | PRKCH | 0.61243421 |
| 48 | NEK6 | 0.60498770 |
| 49 | GRK7 | 0.60119036 |
| 50 | TYRO3 | 0.59380544 |
| 51 | PIK3CG | 0.54160962 |
| 52 | SGK223 | 0.54003199 |
| 53 | SGK494 | 0.54003199 |
| 54 | MAP3K10 | 0.53711003 |
| 55 | TAOK2 | 0.52884383 |
| 56 | JAK1 | 0.49789310 |
| 57 | INSR | 0.47180787 |
| 58 | PIM1 | 0.46624209 |
| 59 | GRK1 | 0.42835629 |
| 60 | STK38 | 0.42776770 |
| 61 | MYLK | 0.41361861 |
| 62 | DAPK1 | 0.39876725 |
| 63 | KIT | 0.38766356 |
| 64 | CAMK1 | 0.37684976 |
| 65 | SGK2 | 0.36701259 |
| 66 | PDK1 | 0.36232159 |
| 67 | OBSCN | 0.36206742 |
| 68 | PTK2B | 0.35065450 |
| 69 | LRRK2 | 0.34276282 |
| 70 | BLK | 0.32719058 |
| 71 | PIM2 | 0.30887728 |
| 72 | CAMKK2 | 0.30562449 |
| 73 | PRKCA | 0.30098691 |
| 74 | VRK2 | 0.29331737 |
| 75 | PLK4 | 0.29052303 |
| 76 | CDK3 | 0.29014064 |
| 77 | INSRR | 0.27499932 |
| 78 | GRK5 | 0.26849045 |
| 79 | PRKCB | 0.26780559 |
| 80 | PIK3CA | 0.25879499 |
| 81 | SGK1 | 0.25460331 |
| 82 | ABL1 | 0.23954768 |
| 83 | PRKCD | 0.23605350 |
| 84 | MAP3K3 | 0.23014942 |
| 85 | MELK | 0.22887184 |
| 86 | MAPKAPK2 | 0.22846273 |
| 87 | MAP2K6 | 0.22015618 |
| 88 | MAPK13 | 0.21180892 |
| 89 | PRKD2 | 0.19418637 |
| 90 | TIE1 | 0.19318300 |
| 91 | ADRBK1 | 0.18539341 |
| 92 | TAOK1 | 0.18464616 |
| 93 | PRKACA | 0.18157613 |
| 94 | IKBKB | 0.17601252 |
| 95 | PRKD1 | 0.17355677 |
| 96 | MAP3K5 | 0.16524424 |
| 97 | STK39 | 0.16508839 |
| 98 | MAP2K3 | 0.15451491 |
| 99 | FGR | 0.15442871 |
| 100 | PDGFRB | 0.15379428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 8.00830886 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.82356934 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.72985958 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.21595514 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 3.01743107 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.00484947 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.86046927 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.43206019 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.41736834 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.38500226 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.97124209 |
| 12 | RNA polymerase_Homo sapiens_hsa03020 | 1.94283728 |
| 13 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.87129818 |
| 14 | Proteasome_Homo sapiens_hsa03050 | 1.84573697 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.72509523 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.66421946 |
| 17 | Salmonella infection_Homo sapiens_hsa05132 | 1.62764574 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.57162173 |
| 19 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.51668080 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43715970 |
| 21 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.42092585 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.36981696 |
| 23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.21726827 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20587062 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.13518829 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.12049350 |
| 27 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.06040928 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.02959862 |
| 29 | Phototransduction_Homo sapiens_hsa04744 | 0.99658297 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.99500201 |
| 31 | Parkinsons disease_Homo sapiens_hsa05012 | 0.98559005 |
| 32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97400145 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.97159956 |
| 34 | Protein export_Homo sapiens_hsa03060 | 0.93761068 |
| 35 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.92205069 |
| 36 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.83656973 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.81328666 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.79064514 |
| 39 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.75192262 |
| 40 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.74414836 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.73220173 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.72473370 |
| 43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.71930135 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 0.71278365 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70983491 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 0.70827481 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.70489493 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69077168 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.68939991 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68232162 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66277170 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 0.65051137 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.62030406 |
| 54 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60482717 |
| 55 | Olfactory transduction_Homo sapiens_hsa04740 | 0.59573611 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58711568 |
| 57 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58467942 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56949926 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 0.49843587 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49564020 |
| 61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45688247 |
| 62 | Purine metabolism_Homo sapiens_hsa00230 | 0.44924199 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 0.44700516 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44636701 |
| 65 | Ribosome_Homo sapiens_hsa03010 | 0.44503806 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44443133 |
| 67 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43774132 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.42144664 |
| 69 | Huntingtons disease_Homo sapiens_hsa05016 | 0.41386574 |
| 70 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.41249617 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.41045242 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.40916622 |
| 73 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38909359 |
| 74 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.37233560 |
| 75 | Homologous recombination_Homo sapiens_hsa03440 | 0.36432411 |
| 76 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.36111320 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.35829992 |
| 78 | Leishmaniasis_Homo sapiens_hsa05140 | 0.34524141 |
| 79 | Influenza A_Homo sapiens_hsa05164 | 0.33754150 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.30928924 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29316998 |
| 82 | Pertussis_Homo sapiens_hsa05133 | 0.29174564 |
| 83 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.28451536 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.23661079 |
| 85 | Morphine addiction_Homo sapiens_hsa05032 | 0.23455319 |
| 86 | Asthma_Homo sapiens_hsa05310 | 0.22745881 |
| 87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.22384515 |
| 88 | Alcoholism_Homo sapiens_hsa05034 | 0.22380830 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.22050940 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.21583501 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.21472419 |
| 92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.21327141 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21033749 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20048454 |
| 95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.19417727 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.19353693 |
| 97 | Peroxisome_Homo sapiens_hsa04146 | 0.19295954 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.18302216 |
| 99 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.17148296 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.17112643 |

